Close Menu


The $20 million program will support development of tools for NIAID priorities including diagnostics, therapeutics, vaccines, and others.

The schools will use the NIAID grant to expand the Eukaryotic Pathogen Genome Database Resource for five years.

While the system will provide a level of multiplexing that is "more than conventional PCR, but not as high as microarrays in general," the expected cost "is on par with, and in some respects lower than, what hospitals and clinics are paying for real-time PCR."

The institutes have a working group that will review new candidate pathogens and invertebrate disease vectors for the sequencing centers.

The company will use the NIAID funding to develop its synthetic biology technologies.

The Bioinformatics Resource Center will be one of four, under a $67.5 million NIAID program.

The stimulus funding will support centers for wide-ranging studies of the human immune system.

The company will use an SBIR and an STTR grant to develop POC tests for HIV and respiratory diseases.

The grants will support studies of a gene complex associated with immune-mediated diseases.

The program will fund partnerships to develop medical diagnostics through R01 and SBIR grants.


A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.